Latest Articles

Publication Date
A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' - pedestrian.tv

A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: 'Deeply Concerned' pedestrian.tv

Published: June 4, 2026, 5:34 a.m.
I’m Cancer-Free After 14 Years, Says Robin Quivers - Health and Me

I’m Cancer-Free After 14 Years, Says Robin Quivers Health and Me

Published: June 4, 2026, 4:43 a.m.
AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year - SSBCrack

AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year SSBCrack

Published: June 4, 2026, 1:03 a.m.
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 - Karyopharm

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 Karyopharm

Published: June 3, 2026, 10:53 p.m.
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves - Australian Broadcasting Corporation

AUDIO: AstraZeneca pulls critical breast cancer drug from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 9:59 p.m.
Life-saving breast cancer and endometriosis drug to be discontinued - Australian Broadcasting Corporation

Life-saving breast cancer and endometriosis drug to be discontinued Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
Lifesaving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation

Lifesaving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
Life-saving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation

Life-saving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study - apd.cat

The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study apd.cat

Published: June 3, 2026, 3:47 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post

Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post

Published: June 3, 2026, 2:49 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!